Skip to content

Evaluation of the Impact of Tricuspid Regurgitation on Patients Lives. Exploration of Experience and Impact on a Daily Basis.

Evaluation of the Impact of Tricuspid Regurgitation on Patients Lives. Exploration of Experience and Impact on a Daily Basis.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05532956
Acronym
EVOQUE
Enrollment
24
Registered
2022-09-08
Start date
2022-09-30
Completion date
2022-10-31
Last updated
2022-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe Tricuspid Regurgitation Medically Treated and Not Operated (Without Valve Replacement or Repair)

Keywords

Severe tricuspid regurgitation

Brief summary

The purpose of this study is to objectively assess the impact of the pathology on the patient's life so as to best inform the choices of evaluators the French National Authority for Health (HAS) and decision makers the Economics Committee for Health Products (CEPS) through the expression of the patients' feelings themselves. For this, the study will assess the impact of severe tricuspid insufficiency and its symptoms on the quality of life of patients from a physical, psychological and social point of view.

Detailed description

Patients eligible for this study are selected by their cardiologist to participate in one of two interviews: * Individual semi-structured interview lasting 45 minutes to 1.5 hours conducted by a psychologist These interviews are recorded (voice recording by dictaphone). They address the experience of patients with different degrees of severity of the pathology (severe, massive or torrential regurgitation), questioning the different dimensions of the impact of tricuspid regurgitation on their life, as well as the hierarchy of consequences for their lives and their daily lives. * Collective interview lasting 1.5 hours to 2 hours which allows to consolidate the information obtained during the individual interviews in order to best assess the impact of the tricuspid regurgitation on the daily life and the patient experience.

Interventions

None listed

Sponsors

Edwards Lifesciences
CollaboratorINDUSTRY
Gérond'if
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
6 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subject, male or female, at least 60 years old, * Suffering from isolated severe tricuspid insufficiency, * Symptomatic despite medical treatment, * Without tricuspid surgery or transcatheter tricuspid surgery, and/or not eligible for surgery, * Potentially eligible for tricuspid transcatheter therapy (repair or replacement), without considering purely anatomical criteria related to the valve, * Not suffering from refractory heart failure (stage D) requiring heart transplant or DMCA (mechanical circulatory assist device), * Without cognitive impairment, * Not suffering from severe deafness, * Speaking and understanding French, * Person not under legal protection and not deprived of liberty

Design outcomes

Primary

MeasureTime frameDescription
Evaluation of the impact of severe tricuspid insufficiency and its symptoms on patients' quality of life4 hoursThese are individual interviews conducted by a psychologist and collective support to consolidate the information obtained during the individual interviews. This is a purely qualitative analysis. It is not intended to create a new questionnaire or validate existing questionnaires

Contacts

Primary ContactIsabelle Dufour
isabelle.dufour@gerondif.org+33 (0) 185781010
Backup ContactAdrien Besseiche, PhD
adrien.besseiche@gerondif.org+33 (0) 185781010

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026